Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Sarah Kassabian

Concepts (16)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Euphoria
1
2018
3
0.150
 Why?
Methylphenidate
1
2018
36
0.150
 Why?
Naltrexone
1
2018
83
0.140
 Why?
Narcotic Antagonists
1
2018
136
0.130
 Why?
Central Nervous System Stimulants
1
2018
139
0.130
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2018
238
0.120
 Why?
Attention Deficit Disorder with Hyperactivity
1
2018
364
0.110
 Why?
Drug Administration Schedule
1
2018
718
0.030
 Why?
Double-Blind Method
1
2018
1660
0.030
 Why?
Treatment Outcome
1
2018
9088
0.010
 Why?
Young Adult
1
2018
10471
0.010
 Why?
Adolescent
1
2018
17853
0.010
 Why?
Adult
1
2018
30553
0.010
 Why?
Male
1
2018
55606
0.010
 Why?
Female
1
2018
59520
0.010
 Why?
Humans
1
2018
114698
0.000
 Why?
Kassabian's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (16) concept(s)
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)